Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential GEMOX/NS in Untreated Pancreatic Cancer
NCT03825328Phase 2Unknown
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin, paclitaxel, tegafur in pancreatic cancer (PC). Status: unknown.
02
Drugs
gemcitabineoxaliplatinpaclitaxeltegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03825328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03825328.